Yahoo Finance

Bio-Rad Announces FDA Clearance of its BioPlex 2200 Syphilis Total & RPR Assay, a Novel Syphilis Testing Method

HERCULES, CA--(Marketwired - Jun 12, 2017) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products, today announced it ...
Yahoo Finance

Bio-Rad Announces U.S. FDA Pre-Market Approval for the BioPlex 2200 HIV Ag-Ab Assay, a Novel Next Generation HIV Diagnostic Test

HERCULES, CA--(Marketwired - Jul 28, 2015) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products, today announced that ...
Medscape

FDA Approves First Assay That Differentiates HIV Types

The US Food and Drug Administration (FDA) has approved the first-ever diagnostic test that differentiates between types of HIV infection. The Bio-Rad BioPlex 2200 HIV Ag-Ab assay (Bio-Rad Laboratories ...
technologynetworks

Bio-Rad Launches Antiphospholipid Syndrome IgG, IgM, and IgA Kits for its BioPlex 2200 System

Bio-Rad Laboratories, Inc. has announced the European and Canadian launch of its BioPlex® 2200 Antiphospholipid Syndrome IgG, IgM, and IgA kits for use on its BioPlex® 2200 system. Antiphospholipid ...